Dexmedetomidine Attenuates Sepsis-Associated Inflammation and Encephalopathy by Modulating the MeCP2/NLGN1 Pathway.
PURPOSE Sepsis-associated encephalopathy (SAE) is a common and serious complication in septic patients that significantly reduces quality of life. Besides its sedative and analgesic effects, dexmedetomidine has been suggested to have potential neuroprotective benefits. This study aims to determine whether dexmedetomidi...